|The ALG10B alg10b (Catalog #MBS9225715) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The ALG10B alg10b product has the following accession number(s) (GI #61966697) (NCBI Accession #NP_001013642.1) (Uniprot Accession #Q5I7T1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Putative alpha-1,2-glucosyltransferase, which adds the third glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation. Transfers glucose from dolichyl phosphate glucose (Dol-P-Glc) onto the lipid-linked oligosaccharide Glc(2)Man(9)GlcNAc(2)-PP-Dol. When coupled to KCNH2 may reduce KCNH2 sensitivity to classic proarrhythmic drug blockade, possibly by mediating glycosylation of KCNH2.
Cellular Location: Cell membrane; Multi-pass membrane protein. Tissue Location: Highly expressed in heart, placenta, liver, kidney and pancreas. Weakly expressed in lung, skeletal muscle and brain. Cardiovascular Abnormalities, Congenital Abnormalities, Heart Defects, Congenital, Heart Diseases are some of the diseases may be linked to ALG10B Antibody (C-term) Blocking peptide. The following patways have been known to be associated with this gene. ALG10B also interacts with the following gene(s): KCNH2. Muscle tissues are correlated with this protein.